A/S Novo Insider Trading $KALV KalVista Pharmaceuticals, Inc.

Get the latest insider transactions of A/S Novo. A/S Novo is 10% Owner in HTG MOLECULAR DIAGNOSTICS, INC ($HTGM) and 10% Owner in BIOMIMETIC THERAPEUTICS, INC. ($BMTI) and 10% Owner in Apollo Endosurgery, Inc. ($LPTN) and 10% Owner in Inogen Inc ($INGN) and 10% Owner in Tobira Therapeutics, Inc. ($TBRA) and 10% Owner in KalVista Pharmaceuticals, Inc. ($KALV) and 10% Owner in CoLucid Pharmaceuticals, Inc. ($CLCD) and 10% Owner in REATA PHARMACEUTICALS INC ($RETA) and 10% Owner in ANAPTYSBIO INC ($ANAB) and 10% Owner in iRhythm Technologies, Inc. ($IRTC) and 10% Owner in Milestone Pharmaceuticals Inc. ($MIST) and 10% Owner in Ophthotech Corp. ($OPHT) and 10% Owner in Flexion Therapeutics Inc ($FLXN) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Corvus Pharmaceuticals, Inc. ($CRVS) and 10% Owner in Bolt Biotherapeutics, Inc. ($BOLT) and 10% Owner in Checkmate Pharmaceuticals, Inc. ($CMPI) and 10% Owner in Morphic Holding, Inc. ($MORF) and 10% Owner in Praxis Precision Medicines, Inc. ($PRAX) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Reneo Pharmaceuticals, Inc. ($RPHM) and 10% Owner in Entasis Therapeutics Holdings Inc. ($ETTX) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX) and 10% Owner in Edgewise Therapeutics, Inc. ($EWTX) and 10% Owner in Aligos Therapeutics, Inc. ($ALGS) and 10% Owner in SPRUCE BIOSCIENCES, INC. ($SPRB) and 10% Owner in Harmony Biosciences Holdings, Inc. ($HRMY).